Cergutuzumab amunaleukin Uses, Dosage, Side Effects and more
Cergutuzumab amunaleukin is under investigation in clinical trial NCT02004106 (A Study to Evaluate Safety, Pharmacokinetics, and Efficacy of RO6895882 in Participants With Advanced and/or Metastatic Solid Tumors).
| Attribute | Details |
|---|---|
| Trade Name | Cergutuzumab amunaleukin |
| Generic | Cergutuzumab amunaleukin |
| Cergutuzumab amunaleukin Other Names | Cergutuzumab amunaleukin |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
